The rapid development of analytical and preparative methods for the identification and purification of proteins has essentially widened our knowledge about human plasma proteins in the last twenty years. In particular, the immunological identification techniques and chromatographical methods have demonstrated the variety of plasma proteins. In the past and still today plasma proteins are highly purified and physicochemically well-characterized, without knowledge of their biological function.
In Table I , for example, five plasma proteins are listed, which have been described for a long time and which could be only characterized later on with regard to their biological function. There are different reasons for this: In the case of the cold-insoluble globulin, which has already been described 27 years before the discovery of its biological function, the decisive indication to its function was obtained by both isolation of the protein from cells and by the exchange of specific antiserum between the laboratories, which were interested in this protein.
For the first time we described the two inhibitors a1-antitrypsin and Clinactivator as cal-glycoprotein (3.5) and a2-neuramino glycoprotein. As it turned out later on, they were physicochemically and immunologically identical with 299 
TABLE I
Human plasma proteins, which are isolated and physicochemically well-characterized before the discovery of their biological function the proteinase inhibitors, but did no longer have a biological inhibitor capacity.
We had destroyed this property by the application of acid, which we used for purification of the proteins. In the case of the a2-macroglobulin, which could also be highly purified 8 years before the discovery of its biological activity, the former use of ammonium sulfate at alkaline pH value and the release of ammonia had caused the destruction of the biological activity. Also the Gc-globulin has been known for a long time, particularly due to its genetic polymorphism, until its identity 1. Well-characterized human plasma proteins o f unknown function This group includes eight proteins, five of them have been isolated for the first time by our laboratory and the other three by the Institute of K. Schmid in Boston. The proteins which are present in the plasma in partially well determinable quantities, are listed in the table according to their electrophoretic mobility.
Some of them had been isolated more than 15 years ago, but up to 1.1. Galactoglyco protein Galactoglycoprotein (GGP) has been recently isolated in a homogeneous form by K. Schmid et al. (1980) from the supernatant of the Cohn-fraction V by means of DEAE-cellulose and gelfiltration through Sephadex G-100. It has a molecular weight of 81,000 dalton. The chemical composition of this protein is rather unusual and deviates from the composition of all other serum glycoproteins known up to now. The carbohydrate content is about 75% and consists of N-acetyl neuraminic acid (23%), hexoses (23.3%)-(21% galactose, 2.3% mannose)-glucosamine (13%), galactosamine (10%) and fucose (1%). The protein content is about 25% of the total weight. It consists of 213 amino acids and is particularly rich in threonine and serine (42 respectively 26 residues). GGP is therefore a super-glycoprotein with numerous N-and O-glycosidically linked heteropolysaccharide chains. The polypeptide moiety is single-chained and does not contain disulfide bonds. Glucose, hydroxylysine and hydroxyproline, which exist in collagen-like proteins, are not contained. The isoelectric point is at pH 2.45. An electrophoretic microheterogeneity could not be found. The glycoprotein cannot be stained with the usual dyes like Amido black or azocarmine. It can be only identified by carbohydrate staining. It was not yet possible to characterize the GGP immunochemically, therefore its serum concentration is still unknown.
a1B-Glycoprotein
We formerly described a1B-glycoprotein (a1B) ras an easily precipitable al-glycoprotein . Later on it turned out that it is identical with the ca1B, observed by Burtin (1964) 
in immunoelectrophoresis .
It has a molecular weight of 68,000 dalton (unpublished data) and a carbohydrate content of 13.3%. N-acetylgalactosamine is not contained. In the presence of sodium dodecyl sulfate (SDS) about 50% of the molecules dissociate into two subunits with molecular weights of approximately 50,000 and 20,000 dalton, whereas the rest remains unchanged. Reduction of the protein has no additional effect. This means that a1B probably exists in two forms in the serum, as a molecule with one chain and as a molecule with two chains, in which the two subunits are hold together by non-covalent bonds. On the other hand it may be, however, that with one part of the protein, already in the serum or during purification, a splitting by limited proteolyses in the peptide chain occurred, which could also be an explanation for the presence of subunits. Like most of the other glycoproteins also a1B electrophoretically has a microheterogeneity with isoelectric points between pH 4.4 and 4.6. a1B is contained in the serum of healthy adults in a normal mean concentration of 22 mg/dl.
a1T-glycoprotein
We have isolated the a1T-glycoprotein (a1T) for the first time in 1964 and described it under the name tryptophan-poor a1-glycoprotein . It is a single-chain glycoprotein with a molecular weight of 85 ,000 dalton (unpublished data). It has a carbohydrate content of 15%. Since galactosamine is not contained, only oligosaccharide chains may exist, which are N-glycosidically linked with asparagine. The amino acid composition does not show anything remarkable, only the tryptophan content is very low with 0.3%. As a result the relatively low extinction coefficient of 4.5 can be observed. The isoelectric point of a1T is at pH 4.45.
In normal adult serum a1T is contained in a mean concentration of 7.4 mg/dl. 1.5. 3.1S leucine-rich a2-glycoprotein The 3.1S leucine-rich a2-glycoprotein (LRG) has been for the first time isolated by us in 1977 (Haupt and Baudner, 1977) . It is a single-chain glycoprotein with a molecular weight of approximately 50,000 dalton and a carbohydrate content of 22.9%. The carbohydrate moiety consists of: galactose (4.1%), mannose (3.8%), fucose (0.3%), N-acetylglucosamine (8.1%) and N-acetyl neuraminic acid (6.6%). Thus the molecule contains only N-glycosidically linked oligosaccharide chains. The extremely high leucine content of nearly 17% is a remarkable characteristic of the amino acid composition, where every fifth amino acid is leucine. In the free and in the molecular sieve electrophoresis at pH 8.6 LRG is homogeneous. However, the isoelectric focusing shows a microheterogeneity with isoelectric points between pH 3.8 and 4.1.
The average content of LRG in adult serum is 2.1 mg/dl.
1.6. 8Sa3-gly co pro to in We have purified and described 8Sa3-glycoprotein for the first time in 1971 as a glycoprotein with a molecular weight of 220,000 dalton . The carbohydrate content is relatively high and amounts to 31.4%, 11% of which belong to neutral sugars (galactose:mannose = 1:2), 10.8% to hexosamines (1.6% of which is N-acetylgalactosamine), 9.2% to sialic acid and 0.4% to fucose. Thus the protein contains both alkaline-stabile and alkaline-labile oligosaccharide chains. 8Sa3-glycoprotein has a tetrameric structure with similar or even identical subunits (molecular weight approximately 50,000) (unpublished data). Two dissulfide dimers are linked together by non-covalent bonds and form the native protein. The protein is electrophoretically homogeneous at pH 8.6 and in molecular sieve electrophoresis, however, it splits into several bands (isoelectric point: 4.2 to 4.6) during isoelectric focusing. (Bergstrand and Czar, 1956) . It is one of the dominant plasma proteins in the early phase of the fetal stage. AFP is found to be synthesized in various tissues such as fetal liver, yolk sac, gastrointestinal tract and in the placenta.
The serum concentration of AFP reaches its highest value in human fetuses approximately in the 15th week of gestation with about 300 mg/dl, then steadily decreasing to approximately 5 to 10 mg/ dl in umbilical cord serum at birth. In the serum of children and adults only values of approximately 0.002 to 0.01 mg/ dl are found.
The AFP became particularly interesting when Abelew et al. (1963) found in 1963 highly increased serum values in mice with experimentally produced liver carcinoma and one year later Tartarinov (1964) found these values in man, also having a primary liver cell carcinoma. From that time a torrent of papers reported on experiments with AFP and about its properties. According to our present knowledge AFP is a single-chain glycoprotein with a molecular weight of app. 60,000 to 70,000 dalton and a carbohydrate content of about 4% (Nishi, 1970; Rusolahti and Seppala, 1971; Alpart et al., 1972; Al-Awgati, Gordon and Chard, 1978) . A microheterogeneity of the AFP can be demonstrated by several electrophoresis techniques. The isoelectric points range between pH 4.85 and 5.2 (Alpart et al., 1972) . Also polymer forms were found, which are held together by intermolecular disulfide bonds (Yachnin et al., 1977) . The primary structure of AFP is very similar to albumin. Amino acid sequence analyses of fragments of AFP and certain sequence regions of albumin show a remarkable homology (Ruoslahti and Terry, 1976 ). Both proteins cross-react immunologically, when they are modified by reduction and alkylation (Ruoslahti and Engvall, 1976) . These results led to the conclusion that AFP and albumin may have a common ancestral gene. AFP and albumin also share the property of connecting low-molecular weight substances like dyes (Endo et al., 1974) , fatty acids (Parmelae, Evenson and Deutsch, 1978) , bilirubin (Ruoslahti, Estes and Seppala, 1979) , tryptophan (Ingvarsson and Carlsson, 1978) , and Cu++ (Aoyagi, Ikenaka and Ichida, 1978) . These physicochemical, immunological and functional similarities between AFP and albumin and the fact that the serum values of these two proteins show a reciprocal variance during the fetal development, led to the speculations that AFP could have similar functions in the fetus like albumin in adults.
The observed strong affinity of AFP from murine species to estrogen (Uriel, De Nechaud and Dupiers, 1972) could not be confirmed for both human AFP and the AFP of some other species (Nunez et al., 1974) . Also the indications about the immunosuppressive properties, which AFP is supposed to have with regard to human lymphocyte cultures, are quite contradictory (Sell and Becker, 1978) . Our own tests do not show such an effect (Johansson et al ., 1976 ). Thus the hypotheses concerning possible specific function of AFP, like blockage of estrogen effects and control of the immune response are not yet proved.
The clinical significance of AFP (Lamerz and Fateh-Moghadam, 1975 ) is based on the regular and increasing production in primary liver cell carcinoma, more rarely in teratogenetic tumors. In tumor diseases it serves in particular for both control of the course after therapeutic treatment and surgery. A slight and temporary increase of the AFP-serum level can be sometimes observed in several other primary tumors with a secondary liver involvement and in some inflammatory gastrointestinal diseases, particularly of the liver (hepatitis, cirrhosis). Also in gynecology the AFP gains a great deal of importance (gastational age, fetal distress syndrome, malformations, hydatidiform mole chorion carcinoma).
a1-Acid glycoprotein
The a1-acid glycoprotein (a1S) has already been isolated in a homogeneous state 30 years ago by Winzler and coworkers (Weimer, Mehl and Winzler, 1950) . The carbohydrate content, which is extremely high for a plasma glycoprotein, has already been recognized at that time, though one carbohydrate element the N-acetyl neuraminic acid has been discovered only 2 years later as a substitute for a1S and other glycoproteins (Werner and Odin, 1952) . Due to its good solubility properties to various protein precipitants and to the very low isoelectric point (pH 2.7), several laboratories all over the world have been engaged with the isolation and characterization of a1S.
Today ca1S is one of the best physicochemically characterized glycoproteins of the human serum, thanks to the excellent work of K. Schmid and coworkers (1975) . The molecular weight is 41,000 dalton. 40% of the molecule consist of carbohydrates. The carbohydrate elements are: hexoses 14.3% (quotient galactose/mannose=l.4), N-acetyl-D-glucosamine 14.1%, L-fucose 1 % and N-acetyl neuraminic acid 11.4%. The complete amino acid sequence is known. The protein consists of a single polypeptide chain of 181 amino acids. Five heteropolysaccharide units are N-glycosidically linked with asparagine residues in the positions 15, 38, 54, 75 and 85 in the N-terminal part of the molecule. The primary structure of the carbohydrate units of desialyzed a1S is elucidated (Fournet et al., 1978; Schmid et al., 1979) . They can be grouped into five classes. Two classes designated A and B possess the known bi-respectively triantennary structures. A third new class designated C proved to be tetraantennary in its structure, whereas the other classes designated BF and CF are, in comparison with the structures of classes B and C, characterized by an additional fucose residue in a hitherto unknown position and linkage. In pooled a1S each of the five glycosylation sites can have carbohydrate units with different structures. The polypeptide chain contains two intramolecular disulfide bonds, which connect the half-cystine residues in position 5 with 147 and position 72 with 164, respectively. 21 of the 181 amino acids of the a1S can be replaced by other amino acids. All amino acid substitutions with the exception of two can be explained by single base changes in the codon. Until today such a high degree of substitution has been found in no other glycoprotein than in the immunoglobulins.
Desialyzed ca1S reveals the existence of genetically determinated variants, which must be caused by amino acid substitutions and can be demonstrated by means of certain electrophoretic techniques. Essentially three phenotypes were found: FF, SS and FS. The electrophoretic polymorphism, however, which is found at native a1S, probably results not only from amino acid substitutions but also from the structural variability of the oligosaccharide chains and from the different linkages between the terminal sialic acid to the different carbohydrate atoms of the galactose.
Certain amino acid sequence areas of the a1S indicated the presence of a significant homology to certain regions of the H-and L-chains of the IgG (Schmid et al., 1979) . Another segment (position 112-132) was found to be related to the a-chain of haptoglobin, which itself is also related to the immunoglobulins (Emura, 1971) . It is therefore assumed that the ce1S is probably related to the immunoglobulins and that it is probably diverged from the evolutionary tree prior to the formation of the primitive IgL-chain.
The homology between a1S and the immunoglobulins becomes more comprehensive by the result that ca1S is not only synthesized in the liver but also in leukocytes, in the same or similar cells, producing the immunoglobulins (Gahmberg and Andersson, 1978) . Lymphocytes, granulocytes and monocytes synthesize the ct1S as a protein, which is integrated into the membrane, in a pro-form with a molecular weight of 52,000 dalton. From there it is apparently subsequently released as a soluble serum form with a molecular weight of 41,000 dalton. The normal mean concentration of ca1S in the serum of healthy adults is 90 mg/dl, the normal range is between 55 and 140 mg/dl. Clinically it belongs to the group of the acute phase proteins and is increased in the serum of patients with inflammatory processes, rheumatic arthritis, at several tumors, after major operations and during pregnancy. Through the detection of the site of synthesis of ca1S in the leukocytes the elevated serum concentrations, which are found in diseases with leukocyte proliferation, can be partially explained.
Additional properties of the ca1S are the binding capability of steroids (Kerkay and Westphal, 1968) and basic drugs like aprenolol and imiparine (Piafsky and Borga, 1977) , quinidine (Fremdstad et al., 1976) and dipyridamole (Subbarao et al., 1977) , as well as inhibition of the platelet aggregation being induced by adenosine diphosphate respectively epinephrine (Snyder and Coodley, 1976) . Some years ago we were able to show that a small part of the ca1S is covalently linked with albumin ) and recently we found out that the same amount exists as disulfide dimerous ca1S (unpublished data).
a1-Antichymotrypsin
Nearly 20 years ago we found, in connexion with the purification of a1-antitrypsin, a protein, which was unknown so far. We called it ct1x-glycoprotein, since we did not yet know any biological property (Schultze, Heide and Haupt, 1962b ). In 1965 we were able to demonstrate that this protein inhibits chymotrypsin very specific, but not trypsin, plasmin or thrombin ). So we called it cal-antichymotrypsin (a1x) and we took it up into the group of the proteinase inhibitors (Heimburger, Haupt and Schwick, 1971) . Its biological significance, however, is still today unknown.
a1x is a single-chain glycoprotein with a carbohydrate content of 26.80. Galactose/mannose (11%), N-acetylglucosamine (8%), N-acetyl neuraminic acid (7%) and fucose (0.8%) participate as carbohydrate elements in the formation of the oligosaccharide chains. N-acetylgalactosamine is not contained. The molecular weight of 68,000 dalton which has been calculated by means of the chymotrypsin binding, corresponds very well to the molecular weight of 65,000 dalton, which was found by sedimentation equilibrium in the ultracentrifuge (Travis, Garner and Bowen, 1978a) . At the isoelectric focusing a microheterogeneity with isoelectric points between pH 3.75 and pH 4.0 can be observed.. The molecule has only one disulfide bond and is therefore relatively labile, particularly in an acidic solution (pH 5) and at higher temperatures (30 min, 56 C). According to the amino acid sequence analyses at the N-terminus of a1x and a1-antitrypsin, no sequence homology exists in the first amino acids. A strong correlation in the structure of both protein exists, however, between the residues 16-27 of the a1x and the residues 33-45 of the a1-antitrypsin (Travis et al., 1978b) . Arginine, which is rarely terminal, is the amino-terminal amino acid, not only in a1x but also in the inter-a-trvpsin inhibitor.
According to investigation of Ohlsson (1971) the affinity of chymotrypsin to a1x is smaller than to a1-antitrypsin and to ce2-macroglobulin. Since also the serum concentration of these two proteins is considerably higher than the one of a1x and the presence of chymotrypsin in the serum is very rare (pancreatitis, pancreas carcinoma), it seems to be doubtful that it should be the true physiological role of a1x, to control the activity of chymotrypsin. Havemann (1974), and Rindler-Ludwig and Braunsteiner (1975) , have found that a1x also inhibits chymotrypsin-like, cationic proteins from granulocytes. Ohlsson and Akesson (1976) were able to confirm this and to show that the affinity of these chymotrypsin-like granulocyte proteins to a1x is higher than to a1-antitrypsin, however, the highest affinity is to a2-macroglobulin. In recent investigations Travis et al. (1978) also suppose that one of the primary functions of a1x could be inactivation of leukocyte cathepsin G. Therefore, it should play an important role in the early stage of inflammable processes, since a2-macroglobulin is not able to penetrate into the extravasal space because of the high molecular weight. This assumption is also supported by the fact that the serum concentration of a1x can, in the beginning of the acute stage of many diseases with leukocyte proliferation, increase up to the quadruple of the normal value within 8 hr (Aronson et al., 1972) .
The normal mean concentration of a1x in the serum of adults is 45 mg/dl. In fetal plasma the values are very low up to delivery, but increase rapidly during the first weeks of live. The a1x-content in the new-born serum is about 10 mg/dl. As already mentioned, a1x is, with regard to its clinical aspect, a very sensitive acute phase reactant, similar to the C-reactive protein.
9.5S al-glyco protein
In 1972 we have isolated a protein, which was new for us at that time and which we called metal-binding 9.5Sa1-glycoprotein (a1M) because of its physicochemical properties . demonstrated in 1974 that this protein is immunologically identical with the so-called P-component (Cathcart, Comerford and Cohen, 1965) of the human plasma and the pentagonal structure (Bladen, Nylen and Glenner, 1966) , which has been found by means of the electron microscope in organs with amyloid deposits. The a1M is also identical with the Clt protein, described by Assimeh and Painter (1975) and Pinteric et al. (1976) , which was erroneously considered to be a fourth subcomponent of the Cl-complex of the complement system (Painter, 1977; Cooper and Ziccardi, 1979) . Thus the same protein received four different names by a series of independent investigations. According to our results a1M has a carbohydrate content of 12.8% . A somewhat lesser content of about 11.2% was found by Thompson and Enfield (1978) . Only galactose, mannose, N-acetylglucosamine, neuraminic acid and traces of fucose participate in the formation of the oligosaccharide chains, which might be N-glycosidically bond to asparagine (Thompson and Enfield, 1978; Uhlenbruck et al., 1979) . Electrophoretically the a1M is homogeneous and its isoelectric point is at pH 5.0. The data reported about the molecular weight vary between 233,000 (Pinteric et al., 1976) , 300,000 (Binnete et al., 1974) and 308,000 dalton . The molecule consists of 10 identical subunits, which are held together by non-covalent bonds. Also in case of the subunits the data about the molecular weight are different, e.g.:23,000 (Pinteric et al., 1976), 25,000 (Thompson and Enfield, 1978; Benson and Skinner, 1978) and 30,000 dalton are reported. Electron optical investigations confirm the decamer structure of the protein: two regular pentagons, each containing five subunits, are arranged in two layers (Pinteric et al., 1976) . In the presence of strong saline solutions (1 M NaCI) (unpublished data) in 5 M urea and in 1 M propionic acid half-molecules with a molecular weight of about 150,000 dalton are obtained . This means that the non-covalent bonds between the two pentagonal layers are of lower affinity than those being inside a pentagon . According to the amino acid sequence analysis of the first 30 amino acids at the N-terminal region , a great homology exists between the a1M and CRP: 18 of these 30 amino acids are in identical positions (Thompson and Enfield , 1978) . Also the size and the composition of the BrCN-fragments are similar to CRP . Another conformity between these two proteins is the binding of Ca-ions; furthermore , cr1M complexes with other bivalent metal-ions like barium, strontium, cobalt , zinc and especially nickel. It can be crystallized from its compound with calcium and nickel . In reference with its metal-combining properties it is worth to be mentioned that the protein does not contain r-carboxyglutamic acid (Thompson and Enfield, 1978) . The a1M has a high affinity to polyanions , for example CM-cellulose, agar or heparin and interacts with IgG to a variable extent in the presence of calcium (Cooper and Ziccardi , 1979) . Uhlenbruck et al. (1978) have observed a totally unexpected precipitationreaction between a1M and asialoceruloplasmin. With regard to galactans a1M shows a calcium-dependent, lectin-like property (Uhlenbruck et al ., 1978) .
According to our determinations the average normal value in serum of healthy donors is 5.5 mg/dl . Other investigators reported 4.3 (Peppys et al., 1978), 4.4 (Thompson and Enfield, 1978) and 7 .47 mg/dl (Scinner et al., 1979) as mean values.
We do not know very much about the clinical and diagnostic importance of a1M. However, one can say that in spite of the ultrastructural and sequence similarities of a1M and CRP, a1M does not share the property of being an acutephase reactant (Scinner et al., 1979) . Sera from persons with various clinical types of amyloidosis, connective tissues diseases and bacterial pneumonia did not differ significantly from normal values. Only a slightly elevation of a1M was noted in sera from patients with inflammatory and neoplastic diseases (Scinner et al., 1979) . In patients with hepatic diseases, however, the levels of a1M are significantly depressed, supposing that its measurement might be of value in their management (Peppys et al., 1978) .
Inter-a-trypsin-inhibitor
We isolated and characterized the inter-ca-trypsin-inhibitor (lcd) physicochemically in 1965 . Its name is derived from the property to inhibit trypsin in stoichiometric quantities and from its electrophoretic mobility, which was between the one of the formerly known a1-and a2-proteinase inhibitors. Later on it turned out that the Icrl is identical with the protein jr, which Steinbuch and Loeb isolated in 1961 (Steinbuch and Loeb, 1961) .
IcI is a glycoprotein with a carbohydrate content of 8%. The carbohydrate content consists not only of alkali-stabile oligosaccharide chains, which are N-glycosidically linked to aspiragine, but also of N-acetylgalactosamine-containing oligosaccharide chains, which are alkali-labile and O-glycosidically linked to serine respectively threonine. Its molecular weight amounts to approximately 160,000 dalton. The molecule consists of one polypeptide chain, which is very sensitive against proteolytic enzymes. Besides the native form, already two fragments of the IcI are found in fresh serum. The smaller one is bearer of the inhibitor capacity and has a molecular weight of about 34,000 dalton. According to this fragment is identical with the acidstabile proteinase inhibitors, which Peanasky and Laskowsky (1953) and Schulman (1955) had found in the serum and Astrup (Astrup and Sterndorf, 1955) had found in urine. It is also identical with the low-molecular weight inhibitor of the bronchial secretion, of which it has 80% of the total inhibitor capacity (Hochstrasser, Reichert and Heimburger, 1973) . The acid-stabile 34,000 daltonfragment is a glycoprotein. By partial tryptical proteolysis an active fragment with a molecular weight of 14,000 dalton can be obtained not only from IaI but also from the physiological 34,000 dalton-fragment. According to the amino acid sequence analyses this fragment has a defined homology to the famous Kunitz-inhibitors (Hochstrasser, Wachter and Bretzel, 1976) . It consists of two covalently connected domains. The domain lacking antitryptic activity is the N-terminal part of the 14,000 dalton-fragment, whereas the domain with antitryptic activity represents the C-terminal part. The latter is probably identical with the C-terminus of the IaI. Each domain contains three disulfide bonds. In addition to the two domains the 14,000 dalton-fragment contains an N- terminal peptide, which contains a carbohydrate moiety Wachter et al., 1979; Wachter and Hochstrasser, 1979) . According to Hochstrasser et al. (1977) the humoral IaI must be definated as precursor of the acid-stabile proteinase inhibitor (34,000 dalton-fragment). It is released from lcd by means of permanent limited intravasal proteolysis and then glomerulary filtrated. According to in vitro investigations granulocyte elastase is the most potent of the enzymes studies so far, being able to cause the release. Since inflammatory processes cause an increased liberation of proteolytic enzymes from polymorphonuclear leukocytes and at the same time increased serum values and excretion rates of the 34,000 dalton-fragment are found in patients with such diseases, Dietl et al. (1979) supposed that the splitting of IaI is also caused in vivo by granulocyte elastase. Contrary to the native IcI, which only inhibits trypsin and chymotrypsin very weak, the acid-stabile fragment is a strong trypsin-chymotrypsin-inhibitor . Therefore, it is possible that the antitryptical fragment fulfills and proper biological function being still unknown, and not the Icd. According to Fritz et al. (1972) lcd also inhibits acrosin of the spermatozoans.
The average serum concentration of lcd of healthy adults is at 45 mg/dl. Hochstrasser et al. (Hochstrasser et al., 1974a (Hochstrasser et al., ,b, 1977a Hochstrasser, Niebel and Rampart, 1977; Rasche, Hochstrasser and Mietens, 1977) found in several clinical examinations an increased metabolism of IaI, especially in inflammatory diseases. In adult patients this caused an increased production of the tissuepenetrable, acid-stabile fragment of 34,000 dalton and increased values of the acid-labile degradation products of IaI, the latter can be immunologically detected in the serum. Premature and new-borns with inflammatory diseases having an increased metabolism of the IcI, which leads very often to deficiencies in the serum. Patients with malignant tumors likewise show an increased release of the 34,000 dalton-fragment. A low-molecular weight glycoprotein, which has been isolated by Rudman et al. (1976) from the urine of a patient with acute myelocytic leukemia, could be recently identified as a fragment of IaI (Chawla, Wadsworth and Rudman, 1978) . This fragment, which is probably identical with the acid-stabile 34,000 dalton-fragment, is excreted in the urine of patients with neoplastic diseases in 30 to 60% of the cases in quantities of 100 to 500 mg per day. The rate of excretion in the urine of normal persons is below 1 mg per day.
a2-HS-glyco protein
a2-HS-glycoprotein (a2HS) was found originally by Heremans (1960) in the fraction of the human serum, which is soluble in presence of zinc ions and he called it ca2Z-globulin. Independently, Schmid and Burgi (1961) found in the supernatant of the Cohn-fraction V a protein, which was easily precipitable with barium ions and which they called Ba-c2-glycoprotein. Schultze et al. (1962d) were then able to show that the two proteins are immunologically identical and named it a2HS-glycoprotein, according to the initial letters of the names of its discoverers.
a2HS is a single-chain glycoprotein with a molecular weight of 49,000 dalton. Its carbohydrate content is 13.7%. 2.8% of its fall to the share of N-acetylglucosamine and 1.2% to N-acetylgalactosamine (Uhlenbruck et al., 1979) . Thus ate-HS contains both N-and also O-glycosidically linked oligosaccharide chains. Nothing is known about the amino acid sequence and the steriochemical structure. Alanine is the amino-terminal amino acid (Lebreton et al., 1979) . A micro-heterogeneity for a2HS can be identified by isoelectric focusing (unpublished data). The immunoelectrophoretically demonstrable variants of a2HS, which have been found in dependence of the storage period of the serum samples, can be led back to a proteolytic fragmentation of the molecule (Roelke, 1968) . Particularly with regard to plasmin and kallikrein the protein is extremely sensitive (unpublished data).
According to recent investigations a2HS is enriched in the matrix of bone and dentine (Dickson, Poole and Veis, 1975; Trift et al., 1976) . Since it also precipitates in vitro with calcium phosphate complexes (Ashton, Hohling and Trift, 1976 ) and can be purified by zinc-chelat affinity chromatography (Lebreton, 1977) , it can be assumed that a2HS has a metal-combining property (Lebreton, 1979) and is therefore enriched in the matrix of bone and dentine (Trift et al., 1976) . Van Oss et al. (1974) 2.7. 3.8S histidine-rich a2-glyco protein The 3.85 histidine-rich a2-glycoprotein (HRG) has been for the first time isolated and physicochemically characterized by us in 1972 Heimburger et al., 1972) . It is a glycoprotein with a molecular weight of 58,500 dalton and a carbohydrate content of 14%. The oligosaccharide chains contain galactose (2.1%), mannose (4.3%), N-acetylglucosamine (4.4%) and N-acetyl neuraminic acid (3.5%), but no N-acetylgalactosamine and no fucose. In comparison to other serum glycoproteins the HRG has an extremely high histidine content: every tenth amino acid is histidine. According to recent investigations the molecule has a single polypeptide chain (unpublished data). The formerly described splitting of the protein into two subunits, was caused by a preceding action of plasmin. With regard to plasmin it is extremely sensitive. The far ultraviolet circular dichroism spectrum of HRG indicates that the protein has little a-helix but apparently appreciable amounts of j3-sheet and nonregular structures (Morgan, 1978 We do not yet know very much about the clinical and diagnostic significance of HRG. Slightly increased values were found in case of heart diseases and erythropoietic protoporphyria and a slightly decreased HRG-content was found in neuromuscular diseases and lead poisonings. Very interesting, however, is the finding that the HRG-concentration in the serum of women after the first trimester of pregnancy decreases continuously and contains only half of the value (5.6±2.3 dl/mg) of the normal adult concentration at delivery. Five to 15 days post partum the values are back to normal .
Protein S
Protein S was discovered by Di Scipio et al. (1977) in 1977 in connexion with the purification of prothrombin, Factor IX and Factor X from human plasma. Its name results from the fact that it was isolated and characterized in Seattle.
Protein S is a single-chain glycoprotein with a molecular weight of 69,000 dalton and a carbohydrate content of 7.8% (Di Scipio and Davie, 1979) . Electrophoretically it has a microheterogeneity with isoelectric points between pH 5.0 and 5.5. According to the amino acid sequence analysis of the N-terminal region a strong correlation exists to the vitamin K-dependent blood clotting proteins:
prothrombin, proconvertin, Christmas-factor, Stuart-factor and protein C (Di Scipio and Davie, 1979) . With those it has further conformity with regard to: binding to barium citrate (Di Scipio et al., 1977) and phospholipid membranes in presence of calcium ions (Nelsestuen, Kisiel and Di Scipio, 1978) . Therefore, Di Scipio and Davie (1979) believed that protein S is also the precursor of a serin protease and participates in the blood as a protease with limited specificity toward one or more protein or peptide substrates. In connexion with the activation of prothrombin it seems to be of no importance.
The concentration of protein S in the plasma is obviously very low, like in the case of homologous coagulation proteins. From 5 l of plasma only 2 mg of the purified protein can be obtained (Di Scipio and Davie, 1979 Although CRP, which was used for the sequence analysis, derived from pooled material of several patients, no amino acid substitutions were found. According to electron microscopic investigations the subunits of CRP are arranged in cyclic symetry, so that a pentagonal structure can be observed, similar to that reported for 9.55 a1-glycoprotein (Osmand et al., 1977) . The comparison of the sequence analysis of the first 30 amino-terminal amino acids of 9.55 cel-glycoprotein with the sequence analysis of a CNBr-fragment of CRP shows such a high degree of homology between both proteins that they must be coordinated to a new super family, unrelated to any other proteins investigated. A computer comparison of the amino acid sequences of the CRP and the immuno globulins together with the IgL-chains shows only for the C2-region of the IgG a weak homology, which is statistically not significant. Therefore, the former hypothesis of the common evolutionary origin of CRP and immunoglobulins can be no longer maintained (Marchalonis and Weltman, 1971; Osmand, Gewurg and Friedensen, 1977) . In recent years a number of in vitro reactivities have been described which show that CRP obviously is of great importance in the regulation of inflammatory processes and in the defence of infectious diseases. To this belong: activation of the classic complement pathway Volanakis and Kaplan, 1974; Osmand et al., 1975 )-CRP interacts with C-polysaccharide, choline phosphatides, lecithin or sphingomyelin as well as with synthetic poly-cations and natural cationic proteins (Siegel, Rent and Gewurz, 1974; Siegel et al., 1975 )-promotion of phagocytosis (Kindmark, 1971; Mortensen et al., 1976) , inhibition of platelet aggregation and release of mediators (Fiedel and Gewurz, 1976; Fiedel, Simpson and Gewurz, 1977) and interaction with certain subpopulations of T-lymphocytes Croft, Mortensen and Gewurz, 1976) .
We recently found together with Uhlenbruck (1979) that CRP has lectinlike properties with regard to several galactans. Using a test preparation from us, Kindmark could demonstrate in a preliminary animal experiment that CRP protects mice against the lethal dose of pneumococci (Kindmark, 1972) . In spite of these results, the proper biological function of CRP is still unknown.
The concentration of CRP in the serum of healthy adults is between 0.007 to 0.8 mg/dl (Claus, and thus in most cases below the limit of sensitivity of the usual precipitation techniques. During infectious diseases, at inflammatory processes and several other pathological conditions, the concentration in the serum increases quickly and can be up to thousand times higher than in normal cases. Therefore, CRP play an important role in the clinical diagnosis (I-Ianson and Wadsworth, 1979) .
Particularly in rheumatology it seems to be the best single parameter for the estimation of activity. The quantitative determination of CRP can serve as a diagnostic tool to differentiate bacterial from viral infections. Since the CRP-concentrations clearly show the clinical course of bacterial infections, the quantitative estimation may be used to control the therapeutic treatment with antibiotics. The demonstration of increased CRP-levels turned out to be clinically very important for an early diagnosis of the neonatal sepsis and meningitis. Moreover, CRP is the easiest determinable and most reliable parameter for the diagnosis of urinary tract infections with renal involvement. Finally, its determination can be useful in other diseases like myocardial infarction, appendicitis and postoperative complications. Table IV four proteins are listed, which have the property to exist not only in serum but also in other body fluids, often in higher concentrations. Thus none of these proteins has been isolated up to now from serum or serum fractions.
In most cases urine was used particularly from patients with certain renal diseases, which have an increased excretion rate e.g. of al-microglobulin, 3.1. a1-Microglobulin, protein HC, ce1-microglycoprotein a1-Microglobulin (a1m) has been for the first time isolated from the urine of patients with tubular proteinuria and identified in the plasma by Ekstrom et al. (1975 Ekstrom et al. ( ) in 1975 . It is a single-chain glycoprotein with a molecular weight of 26,700 dalton (Ekstrom and Berggard, 1975) . The carbohydrate content is 19.5% and consists of 4.3% mannose, 3.8% galactose, 5.6% glucosamine and 5.8% sialic acid. According to Svensson and Ravnskov (1976) it shall also contain galactosamine. a1m is of yellowish-brown color and thus bearer of a chromophoric group, the nature of which is still unknown. The protein, which is homogenous in its molecular size, shows in the electrophoresis a strong charge heterogeneity, which is still maintained after splitting of the terminal sialic acid. The isoelectric points of the native protein vary between pH 3.6 and pH 4.3. a1m forms non-covalently linked aggregates and exists in the serum complexed with other proteins (IgA, albumin).
In spite of minor discrepancies in the chemical and physicochemical analysis a1m with all its properties resembles protein HC (human complex-forming protein heterogeneous in charge), which Tejler and Grubb (1976) isolated from the urine of normal persons and also cal-microglycoprotein, isolated from the urine of tumor patients, reported by Seon and Pressman (1978) . Immunologically, a1m is closely related to protein HC. It is known from a1m and protein HC that they are localized on the surface of several cell types, inclusively peripheral B-and T-lymphocytes (Takagi et al., 1978) , erythrocytes and fibroblasts (Pearlstein, 1977) . From there these proteins are released into the serum and partially excreted into the urine. The amino acid sequence of the first 20 amino acids at the N-terminus is, except two gaps, identical for protein HC (Frangione et al., 1976) and a1MGP (Seon and . Whether these three very similar proteins are really identical, can be only proved, if their complete amino acid sequence is known. Bernier et al. (1978) recently found that also the histocompatibility antigens A9 and B12 have the same amino-terminal sequence as a1MGP and protein HC. Because of the present results it is therefore supposed that alm, protein HC and a1MGP are related to other cell surface markers (HLA), which play an important role in immunological reactions or that they act as transport proteins with reference to their complex-forming properties with high affinity to some membrane proteins inclusively HLA or their degradation products.
The average concentration of alm in the serum of adults is 5.4 mg/dl and in the umbilical cord serum 2.6 mg/dl. On the average 9 mg are excreted via normal urine within 24 hr (Ekstrom and Berggard, 1977) . Considerably higher values were found in the serum and urine of patients with certain nephropathies (Svensson and Ravnskov, 1976 4. Low-molecular weight trace proteins with basic or r-mobility and unknown function Since the middle of the sixties, beginning of the seventies, the group of K. Schmid discovered several trace proteins, which have a low-molecular weight (Table V) . Most of them have highly basic properties and migrate in the electrophoresis at pH 8.6 to the cathode. Others have the electrophoretic mobility of the slow immunoglobulins, without having a relationship to them. We do not yet know anything about their origin and function. It is possible that they represent fragments of known proteins, which are formed in connexion with activation-or cleavage processes of the complement or blood coagulation system, or they derive from tissues. It is also possible that some of them have a specific biological function, an example for this is the lysozyme. These proteins are not yet characterized immunologically. Therefore, specific antisera could be a valuable tool in clarifying these questions. From the Cohn-fraction III Pandey and have isolated nine basic proteins with different positive electrophoretical mobility. They are carbohydrate-free and called B 1 to B9. Two of them, B2 and B6, exist in a homogeneous form.
4.1. B2 (Iwasaki and Schmid, 1967a ) has a molecular weight of 9,000 dalton. It consists of a polypeptide chain of 81 amino acids and aspartic acid represents the N-terminal and glycine the C-terminal amino acid. The isoelectric and isoionic points are pH 10.1 and 10.7, respectively. ) has a molecular weight of 11,000 dalton. Though the protein still has a certain lysozyme activity, its amino acid composition differs from the lysozyme.
B6 (Pandey and
Two more carbohydrate-free proteins with r mobility, a 2S 72-globulin (Iwasaki and Schmid, 1967b ) and a 0.6S r2-globulin (Nimberg and Schmid, 1972) , have been isolated from the Cohn-fraction VI.
4.3. 2S r2-globulin (Iwasaki and Schmid, 1967b ) is a single-chain polypeptide with a molecular weight of 14,000 dalton. Tyrosine is the amino-terminal and valine the carboxy-terminal amino acid. In the amino acid composition it differs from the L-chains of the immunoglobulins and carbonic anhydrase B. The electrophoretically homogeneous protein has an isoelectric point of pH 5.9 and an isoionic point of pH 9.0.
4.4. 0.6S r2-globulin (Nimberg and Schmid, 1972) consists of a polypeptide chain of 47 amino acids. The molecular weight is 5,100 dalton. In its amino acid composition the high lysine content of nearly 35% is remarkable as well as the lack of arginine, histidine, methionine, half-cystine and tryptophan. The first six amino acids at the N-terminus are Phe-Gln-Val-Val-Asp-Tyr. Such a sequence does not exist in the primary structure of the constant regions of L-chains and H-chains of IgG, IgA and IgM. It is therefore impossible that 0.6S r2-globulin derives from one of the three major immunoglobulins. Today, through immunization with these proteins, established qualitative and quantitative determinations of human plasma proteins have been made possible in all clinics; with their assistance a clinical diagnosis can be supported or brought to light. One can certainly expect that in the near future many of the human plasma proteins, which were presented in this paper, will become further defined with respect to their functions and that this in turn will contribute to a better understanding of the physiology and pathophysiology of human plasma proteins.
